Showing 1 - 4 results of 4 for search 'Daniela Thurn', query time: 0.03s Refine Results
  1. 1
    Development and Validation of the Amphetamine-Type Stimulants Motive Questionnaire in a Clinical Population

    Development and Validation of the Amphetamine-Type Stimulants Motive Questionnaire in a Clinical Population by Daniela Thurn, Daniela Thurn, Emmanuel Kuntsche, Emmanuel Kuntsche, Emmanuel Kuntsche, Jennifer Anna Weber, Jörg Wolstein

    Published 2017-09-01
    Get full text
    Article
  2. 2
    Intimal and medial arterial changes defined by ultra-high-frequency ultrasound: Response to changing risk factors in children with chronic kidney disease.

    Intimal and medial arterial changes defined by ultra-high-frequency ultrasound: Response to changing risk factors in children with chronic kidney disease. by Frida Dangardt, Marietta Charakida, Scott Chiesa, Devina Bhowruth, Alicja Rapala, Daniela Thurn, Franz Schaefer, John Deanfield, Rukshana Shroff

    Published 2018-01-01
    Get full text
    Article
  3. 3
    The mTOR inhibitor Rapamycin protects from premature cellular senescence early after experimental kidney transplantation.

    The mTOR inhibitor Rapamycin protects from premature cellular senescence early after experimental kidney transplantation. by Uwe Hoff, Denise Markmann, Daniela Thurn-Valassina, Melina Nieminen-Kelhä, Zulrahman Erlangga, Jessica Schmitz, Jan Hinrich Bräsen, Klemens Budde, Anette Melk, Björn Hegner

    Published 2022-01-01
    Get full text
    Article
  4. 4
    The mTOR inhibitor Rapamycin protects from premature cellular senescence early after experimental kidney transplantation

    The mTOR inhibitor Rapamycin protects from premature cellular senescence early after experimental kidney transplantation by Uwe Hoff, Denise Markmann, Daniela Thurn-Valassina, Melina Nieminen-Kelhä, Zulrahman Erlangga, Jessica Schmitz, Jan Hinrich Bräsen, Klemens Budde, Anette Melk, Björn Hegner

    Published 2022-01-01
    Get full text
    Article

Search Tools: